Wong, H. Y., Sung, A. D., Lindblad, K. E., Sheela, S., Roloff, G. W., Romero, K., … Hourigan, C. S. (2018). Molecular testing during AML treatment for early prediction of clinical response. In Journal of Clinical Oncology (Vol. 36, pp. 7047–7047). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.7047

Wong, Hong Yuen, Anthony Derek Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, Kristi Romero, Meghali Goswami, et al. “Molecular testing during AML treatment for early prediction of clinical response.” In Journal of Clinical Oncology, 36:7047–7047. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.7047.

Wong HY, Sung AD, Lindblad KE, Sheela S, Roloff GW, Romero K, et al. Molecular testing during AML treatment for early prediction of clinical response. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 7047–7047.

Wong, Hong Yuen, et al. “Molecular testing during AML treatment for early prediction of clinical response.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 7047–7047. Crossref, doi:10.1200/jco.2018.36.15_suppl.7047.

Wong HY, Sung AD, Lindblad KE, Sheela S, Roloff GW, Romero K, Goswami M, Mulé MP, Destefano CB, Rizzieri D, Dillon LW, Lai C, Hourigan CS. Molecular testing during AML treatment for early prediction of clinical response. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 7047–7047.